The new IQ9N-3P microinverter utilizes gallium nitride technology to deliver 427 VA of peak power and 97.5% efficiency for the 480 V three-phase commercial market.

The new IQ9N-3P microinverter utilizes gallium nitride technology to deliver 427 VA of peak power and 97.5% efficiency for the 480 V three-phase commercial market.

In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management. Understanding the trade-offs between Delta and Wye connections enables ...

Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in early-stage symptomatic Alzheimer’s ...

Mists of Pandaria Classic is launched Phase 3, the Thunder King, on December 9 at 3pm pacific time. The latest phase continues the main Mists Classic story through another concerted war effort event ...

The biggest stories of the day delivered to your inbox.

(NEXSTAR) – A multi-phase scam credited with emptying the financial accounts of numerous Americans – many of whom were nearing the age of retirement – is again making headlines after the FBI recently ...

Pharvaris, a late-stage biopharmaceutical company focused on developing oral bradykinin B2 receptor antagonists for bradykinin-mediated diseases like hereditary angioedema (HAE), has updated the ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in SHASTA-3, SHASTA-4, and MUIR-3, the company’s global Phase 3 ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and ...